Artivion AORT
NYSE AORT
$27.96 -0.86 (-2.98%)
At close: Aug 20, 2026 · 1:25 PM UTC

Artivion (AORT) Net Income towards Common Stockholders (2010 - 2026)

Artivion's (AORT) quarterly Net Income towards Common Stockholders came in at $1.4 million in Q1 2026, up 380.59% YoY from $294843.4 in Q1 2025, and down 41.59% on a QoQ basis from $2.4 million in Q4 2025.

Artivion (AORT) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Artivion (AORT) has 17 years of Net Income towards Common Stockholders data on file, last reported at $1.4 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders rose 380.59% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 154.63% YoY) and the FY2025 annual result came in at $9.8 million, up 173.12% from the prior year.
  • Net Income towards Common Stockholders fell to $1.4 million in Q1 2026, from $2.4 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $7.5 million in Q1 2024 to a low of -$16.5 million in Q4 2024.
  • A 5-year average of -$3.1 million and a median of -$2.3 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders tumbled 314.67% — and 2025, when it soared 384.18%.
  • Tracing AORT's Net Income towards Common Stockholders over 5 years: stood at $2.2 million in 2022, then plunged by 283.26% to -$4.0 million in 2023, then plunged by 314.67% to -$16.5 million in 2024, then surged by 114.72% to $2.4 million in 2025, then plunged by 41.59% to $1.4 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $1.4 million (Q1 2026), $2.4 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 621.86 Mn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 201.00 Mn
10 Artivion 1.36 Bn 1.28 Bn 80.52 Mn -13.51 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.51 Mn
Mar 31, 2026 1.42 Mn
Dec 31, 2025 2.43 Mn
Sep 30, 2025 6.50 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 -505,000.00
Dec 31, 2024 -16.48 Mn
Sep 30, 2024 -2.29 Mn
Jun 30, 2024 -2.12 Mn
Mar 31, 2024 7.53 Mn
Dec 31, 2023 -3.98 Mn
Sep 30, 2023 -9.80 Mn
Jun 30, 2023 -3.38 Mn
Mar 31, 2023 -13.53 Mn
Dec 31, 2022 2.17 Mn
Sep 30, 2022 -13.71 Mn
Jun 30, 2022 -4.26 Mn
Mar 31, 2022 -3.39 Mn
Dec 31, 2021 -20.10 Mn
Sep 30, 2021 10.58 Mn